Vicki L Sato is Director of Denali Therapeutics Inc.. Currently has a direct ownership of 111,056 shares of DNLI, which is worth approximately $2.38 Million. The most recent transaction as insider was on Nov 07, 2024, when has been sold 1,020 shares (Common Stock) at a price of $30.0 per share, resulting in proceeds of $30,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 111K
3.56% 3M change
10.95% 12M change
Total Value Held $2.38 Million

VICKI L SATO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 07 2024
SELL
Open market or private sale
$30,600 $30.0 p/Share
1,020 Reduced 0.91%
111,056 Common Stock
Nov 01 2024
SELL
Open market or private sale
$83,375 $27.07 p/Share
3,080 Reduced 2.67%
112,076 Common Stock
Sep 13 2024
SELL
Open market or private sale
$30,600 $30.0 p/Share
1,020 Reduced 0.88%
115,156 Common Stock
Sep 03 2024
SELL
Open market or private sale
$77,554 $25.18 p/Share
3,080 Reduced 2.58%
116,176 Common Stock
Jul 01 2024
SELL
Open market or private sale
$69,269 $22.49 p/Share
3,080 Reduced 2.52%
119,256 Common Stock
May 31 2024
BUY
Grant, award, or other acquisition
-
5,967 Added 4.65%
122,336 Common Stock
May 15 2024
SELL
Open market or private sale
$34,132 $20.39 p/Share
1,674 Reduced 1.42%
116,369 Common Stock
Apr 15 2024
SELL
Open market or private sale
$30,471 $18.29 p/Share
1,666 Reduced 1.39%
118,043 Common Stock
Mar 15 2024
SELL
Open market or private sale
$33,486 $20.1 p/Share
1,666 Reduced 1.37%
119,709 Common Stock
Feb 15 2024
SELL
Open market or private sale
$30,604 $18.37 p/Share
1,666 Reduced 1.35%
121,375 Common Stock
Jan 16 2024
SELL
Open market or private sale
$30,687 $18.42 p/Share
1,666 Reduced 1.34%
123,041 Common Stock
Dec 15 2023
SELL
Open market or private sale
$38,967 $23.39 p/Share
1,666 Reduced 1.32%
124,707 Common Stock
Nov 15 2023
SELL
Open market or private sale
$31,870 $19.13 p/Share
1,666 Reduced 1.3%
126,373 Common Stock
Oct 16 2023
SELL
Open market or private sale
$34,419 $20.66 p/Share
1,666 Reduced 1.28%
128,039 Common Stock
Sep 15 2023
SELL
Open market or private sale
$39,950 $23.98 p/Share
1,666 Reduced 1.27%
129,705 Common Stock
Aug 15 2023
SELL
Open market or private sale
$40,483 $24.3 p/Share
1,666 Reduced 1.25%
131,371 Common Stock
Jul 17 2023
SELL
Open market or private sale
$49,313 $29.6 p/Share
1,666 Reduced 1.24%
133,037 Common Stock
Jun 28 2023
SELL
Open market or private sale
$49,580 $29.76 p/Share
1,666 Reduced 1.22%
134,703 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
-
4,216 Added 3.0%
136,369 Common Stock
Jun 02 2022
BUY
Grant, award, or other acquisition
-
5,986 Added 4.04%
142,149 Common Stock
Nov 10 2021
SELL
Open market or private sale
$88,131 $52.9 p/Share
1,666 Reduced 1.3%
126,167 Common Stock
Nov 01 2021
SELL
Open market or private sale
$83,383 $50.05 p/Share
1,666 Reduced 1.29%
127,833 Common Stock
Sep 15 2021
SELL
Open market or private sale
$89,131 $53.5 p/Share
1,666 Reduced 1.27%
129,499 Common Stock
Aug 18 2021
SELL
Open market or private sale
$86,116 $51.69 p/Share
1,666 Reduced 1.25%
131,165 Common Stock
Jul 21 2021
SELL
Open market or private sale
$108,440 $65.09 p/Share
1,666 Reduced 1.24%
132,831 Common Stock

Also insider at

BMY
BRISTOL MYERS SQUIBB CO Healthcare
VIR
Vir Biotechnology, Inc. Healthcare
AKUS
Akouos, Inc. Healthcare
ALLO
Allogene Therapeutics, Inc. Healthcare
VLS

Vicki L Sato

Director
New York, NY

Track Institutional and Insider Activities on DNLI

Follow Denali Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNLI shares.

Notify only if

Insider Trading

Get notified when an Denali Therapeutics Inc. insider buys or sells DNLI shares.

Notify only if

News

Receive news related to Denali Therapeutics Inc.

Track Activities on DNLI